DocGo Inc. (NASDAQ:DCGO) Receives Consensus Rating of “Buy” from Brokerages

Shares of DocGo Inc. (NASDAQ:DCGOGet Free Report) have earned an average rating of “Buy” from the five brokerages that are currently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $6.10.

DCGO has been the topic of a number of research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $5.00 target price on shares of DocGo in a report on Friday. Needham & Company LLC reaffirmed a “buy” rating and issued a $7.00 price objective on shares of DocGo in a research note on Thursday, August 8th.

Get Our Latest Research Report on DocGo

DocGo Stock Performance

NASDAQ:DCGO opened at $3.48 on Monday. DocGo has a 52 week low of $2.75 and a 52 week high of $6.90. The firm’s 50-day simple moving average is $3.49 and its 200 day simple moving average is $3.40. The firm has a market cap of $353.45 million, a price-to-earnings ratio of 17.40, a P/E/G ratio of 3.02 and a beta of 0.92.

DocGo (NASDAQ:DCGOGet Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.01). The business had revenue of $164.95 million for the quarter, compared to the consensus estimate of $166.61 million. DocGo had a return on equity of 8.90% and a net margin of 3.97%. Sell-side analysts anticipate that DocGo will post 0.23 EPS for the current year.

Hedge Funds Weigh In On DocGo

Hedge funds have recently made changes to their positions in the stock. Point72 Asset Management L.P. boosted its holdings in DocGo by 1,655.7% in the second quarter. Point72 Asset Management L.P. now owns 116,844 shares of the company’s stock valued at $361,000 after acquiring an additional 110,189 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of DocGo by 31.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after purchasing an additional 9,696 shares during the last quarter. Marathon Capital Management increased its position in shares of DocGo by 2.3% during the second quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock worth $856,000 after buying an additional 6,285 shares during the period. Deerfield Management Company L.P. Series C raised its stake in DocGo by 41.0% during the second quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock worth $22,236,000 after buying an additional 2,091,569 shares during the last quarter. Finally, AQR Capital Management LLC lifted its holdings in DocGo by 58.5% in the second quarter. AQR Capital Management LLC now owns 344,963 shares of the company’s stock valued at $1,066,000 after buying an additional 127,320 shares during the period. 56.44% of the stock is currently owned by institutional investors.

DocGo Company Profile

(Get Free Report

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Read More

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.